239 related articles for article (PubMed ID: 35477723)
1. ASCL1 activates neuronal stem cell-like lineage programming through remodeling of the chromatin landscape in prostate cancer.
Nouruzi S; Ganguli D; Tabrizian N; Kobelev M; Sivak O; Namekawa T; Thaper D; Baca SC; Freedman ML; Aguda A; Davies A; Zoubeidi A
Nat Commun; 2022 Apr; 13(1):2282. PubMed ID: 35477723
[TBL] [Abstract][Full Text] [Related]
2. ASCL1 is activated downstream of the ROR2/CREB signaling pathway to support lineage plasticity in prostate cancer.
Tabrizian N; Nouruzi S; Cui CJ; Kobelev M; Namekawa T; Lodhia I; Talal A; Sivak O; Ganguli D; Zoubeidi A
Cell Rep; 2023 Aug; 42(8):112937. PubMed ID: 37552603
[TBL] [Abstract][Full Text] [Related]
3. ASCL1 Reorganizes Chromatin to Direct Neuronal Fate and Suppress Tumorigenicity of Glioblastoma Stem Cells.
Park NI; Guilhamon P; Desai K; McAdam RF; Langille E; O'Connor M; Lan X; Whetstone H; Coutinho FJ; Vanner RJ; Ling E; Prinos P; Lee L; Selvadurai H; Atwal G; Kushida M; Clarke ID; Voisin V; Cusimano MD; Bernstein M; Das S; Bader G; Arrowsmith CH; Angers S; Huang X; Lupien M; Dirks PB
Cell Stem Cell; 2017 Aug; 21(2):209-224.e7. PubMed ID: 28712938
[TBL] [Abstract][Full Text] [Related]
4. UHRF1 promotes androgen receptor-regulated CDC6 transcription and anti-androgen receptor drug resistance in prostate cancer through KDM4C-Mediated chromatin modifications.
Gao Y; Liu Y; Liu Y; Peng Y; Yuan B; Fu Y; Qi X; Zhu Q; Cao T; Zhang S; Yin L; Li X
Cancer Lett; 2021 Nov; 520():172-183. PubMed ID: 34265399
[TBL] [Abstract][Full Text] [Related]
5. ASCL1 represses a SOX9
Olsen RR; Ireland AS; Kastner DW; Groves SM; Spainhower KB; Pozo K; Kelenis DP; Whitney CP; Guthrie MR; Wait SJ; Soltero D; Witt BL; Quaranta V; Johnson JE; Oliver TG
Genes Dev; 2021 Jun; 35(11-12):847-869. PubMed ID: 34016693
[TBL] [Abstract][Full Text] [Related]
6. Subcellular localisation modulates ubiquitylation and degradation of Ascl1.
Gillotin S; Davies JD; Philpott A
Sci Rep; 2018 Mar; 8(1):4625. PubMed ID: 29545540
[TBL] [Abstract][Full Text] [Related]
7. ASCL1 is a lineage oncogene providing therapeutic targets for high-grade neuroendocrine lung cancers.
Augustyn A; Borromeo M; Wang T; Fujimoto J; Shao C; Dospoy PD; Lee V; Tan C; Sullivan JP; Larsen JE; Girard L; Behrens C; Wistuba II; Xie Y; Cobb MH; Gazdar AF; Johnson JE; Minna JD
Proc Natl Acad Sci U S A; 2014 Oct; 111(41):14788-93. PubMed ID: 25267614
[TBL] [Abstract][Full Text] [Related]
8. Temporal evolution reveals bifurcated lineages in aggressive neuroendocrine small cell prostate cancer trans-differentiation.
Chen CC; Tran W; Song K; Sugimoto T; Obusan MB; Wang L; Sheu KM; Cheng D; Ta L; Varuzhanyan G; Huang A; Xu R; Zeng Y; Borujerdpur A; Bayley NA; Noguchi M; Mao Z; Morrissey C; Corey E; Nelson PS; Zhao Y; Huang J; Park JW; Witte ON; Graeber TG
Cancer Cell; 2023 Dec; 41(12):2066-2082.e9. PubMed ID: 37995683
[TBL] [Abstract][Full Text] [Related]
9. hASH1 nuclear localization persists in neuroendocrine transdifferentiated prostate cancer cells, even upon reintroduction of androgen.
Fraser JA; Sutton JE; Tazayoni S; Bruce I; Poole AV
Sci Rep; 2019 Dec; 9(1):19076. PubMed ID: 31836808
[TBL] [Abstract][Full Text] [Related]
10. Proneural factors Ascl1 and Neurog2 contribute to neuronal subtype identities by establishing distinct chromatin landscapes.
Aydin B; Kakumanu A; Rossillo M; Moreno-Estellés M; Garipler G; Ringstad N; Flames N; Mahony S; Mazzoni EO
Nat Neurosci; 2019 Jun; 22(6):897-908. PubMed ID: 31086315
[TBL] [Abstract][Full Text] [Related]
11. A transcription factor network specifying inhibitory versus excitatory neurons in the dorsal spinal cord.
Borromeo MD; Meredith DM; Castro DS; Chang JC; Tung KC; Guillemot F; Johnson JE
Development; 2014 Jul; 141(14):2803-12. PubMed ID: 24924197
[TBL] [Abstract][Full Text] [Related]
12. TRIM59 is suppressed by androgen receptor and acts to promote lineage plasticity and treatment-induced neuroendocrine differentiation in prostate cancer.
Fan L; Gong Y; He Y; Gao WQ; Dong X; Dong B; Zhu HH; Xue W
Oncogene; 2023 Feb; 42(8):559-571. PubMed ID: 36544044
[TBL] [Abstract][Full Text] [Related]
13. MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer.
Yasumizu Y; Rajabi H; Jin C; Hata T; Pitroda S; Long MD; Hagiwara M; Li W; Hu Q; Liu S; Yamashita N; Fushimi A; Kui L; Samur M; Yamamoto M; Zhang Y; Zhang N; Hong D; Maeda T; Kosaka T; Wong KK; Oya M; Kufe D
Nat Commun; 2020 Jan; 11(1):338. PubMed ID: 31953400
[TBL] [Abstract][Full Text] [Related]
14. Pro-neuronal activity of Myod1 due to promiscuous binding to neuronal genes.
Lee QY; Mall M; Chanda S; Zhou B; Sharma KS; Schaukowitch K; Adrian-Segarra JM; Grieder SD; Kareta MS; Wapinski OL; Ang CE; Li R; Südhof TC; Chang HY; Wernig M
Nat Cell Biol; 2020 Apr; 22(4):401-411. PubMed ID: 32231311
[TBL] [Abstract][Full Text] [Related]
15. Ascl1-induced Wnt11 regulates neuroendocrine differentiation, cell proliferation, and E-cadherin expression in small-cell lung cancer and Wnt11 regulates small-cell lung cancer biology.
Tenjin Y; Kudoh S; Kubota S; Yamada T; Matsuo A; Sato Y; Ichimura T; Kohrogi H; Sashida G; Sakagami T; Ito T
Lab Invest; 2019 Nov; 99(11):1622-1635. PubMed ID: 31231131
[TBL] [Abstract][Full Text] [Related]
16. The proneural gene ASCL1 governs the transcriptional subgroup affiliation in glioblastoma stem cells by directly repressing the mesenchymal gene NDRG1.
Narayanan A; Gagliardi F; Gallotti AL; Mazzoleni S; Cominelli M; Fagnocchi L; Pala M; Piras IS; Zordan P; Moretta N; Tratta E; Brugnara G; Altabella L; Bozzuto G; Gorombei P; Molinari A; Padua RA; Bulfone A; Politi LS; Falini A; Castellano A; Mortini P; Zippo A; Poliani PL; Galli R
Cell Death Differ; 2019 Sep; 26(9):1813-1831. PubMed ID: 30538287
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Karyopherin β1-Mediated Nuclear Import Disrupts Oncogenic Lineage-Defining Transcription Factor Activity in Small Cell Lung Cancer.
Kelenis DP; Rodarte KE; Kollipara RK; Pozo K; Choudhuri SP; Spainhower KB; Wait SJ; Stastny V; Oliver TG; Johnson JE
Cancer Res; 2022 Sep; 82(17):3058-3073. PubMed ID: 35748745
[TBL] [Abstract][Full Text] [Related]
18. Subtype heterogeneity and epigenetic convergence in neuroendocrine prostate cancer.
Cejas P; Xie Y; Font-Tello A; Lim K; Syamala S; Qiu X; Tewari AK; Shah N; Nguyen HM; Patel RA; Brown L; Coleman I; Hackeng WM; Brosens L; Dreijerink KMA; Ellis L; Alaiwi SA; Seo JH; Baca S; Beltran H; Khani F; Pomerantz M; Dall'Agnese A; Crowdis J; Van Allen EM; Bellmunt J; Morrisey C; Nelson PS; DeCaprio J; Farago A; Dyson N; Drapkin B; Liu XS; Freedman M; Haffner MC; Corey E; Brown M; Long HW
Nat Commun; 2021 Oct; 12(1):5775. PubMed ID: 34599169
[TBL] [Abstract][Full Text] [Related]
19. Maintenance of active chromatin states by HMGN2 is required for stem cell identity in a pluripotent stem cell model.
Garza-Manero S; Sindi AAA; Mohan G; Rehbini O; Jeantet VHM; Bailo M; Latif FA; West MP; Gurden R; Finlayson L; Svambaryte S; West AG; West KL
Epigenetics Chromatin; 2019 Dec; 12(1):73. PubMed ID: 31831052
[TBL] [Abstract][Full Text] [Related]
20. Instructing neuronal identity during CNS development and astroglial-lineage reprogramming: Roles of NEUROG2 and ASCL1.
Chouchane M; Costa MR
Brain Res; 2019 Feb; 1705():66-74. PubMed ID: 29510143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
